Cannabis
InvestmentPitch Media Video Features Nextleaf Solutions, a Federally Regulated Manufacturer and Distributor of Cannabis Extracts Including Vapes and Oils
VANCOUVER, British Columbia, July 05, 2022 (GLOBE NEWSWIRE) — InvestmentPitch Media video features Nextleaf Solutions Ltd. (CSE:OILS) (OTCQB:OILFF) (FSE:L0MA), a federally regulated manufacturer and distributor of cannabis extracts including vapes and oils. Nextleaf, the first publicly traded company to be issued a U.S. patent for the industrial extraction and purification of cannabinoids, has been issued 18 U.S. patents, and over 95 patents globally, on cannabinoid processing including distillation and acetylation.
A Media Snippet accompanying this announcement is available by clicking on the image or link below:
For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company including video comments from Paul Pedersen, Founder and CEO of Nextleaf Solutions. The video is available for viewing on “InvestmentPitch” and on “YouTube”. If these links are not enabled, please visit www.InvestmentPitch.com and enter “Nextleaf” in the search box.
The company is a low-cost producer of cannabis oils, and supplier of THC and CBD ingredients to qualified wholesale partners across Canada, which it produces at its multi-patented closed loop extraction plant in a Vancouver suburb, where it transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. Extracts and cannabinoid ingredients produced through the company’s patented process are versatile, and suitable for a wide variety of formulations due to their stability, purity, and neutral characteristics making them the ideal ingredients for anything from vapes, to beverages, edibles, topicals, and more.
In May 2021, the company entered the branded consumer products sector with the acquisition of all rights associated with the award-winning, prohibition-era brand, “Glacial Gold”, a previous category leader in speciality concentrates and extracts, with market validated formulations.
Through its Specialty Molecules division, the company recently produced THC-O under the company’s Health Canada Research Licence in anticipation of commercialization. The company is of the understanding that THC-O is not subject to excise tax as it does not meet the definition of “Total THC” as defined under the Excise Act 2001, which is aligned with the definition of the same in the Cannabis Act.
The shares are trading at $0.075. For more information, please visit the company’s website www.NextleafSolutions.com, contact Jason McBride, Corporate Development, at 604-283-2301 (ext. 219) or email [email protected].
Disclaimer
The information in this InvestmentPitch Media Ltd video is for the viewers information only. Nextleaf Solutions has paid a fee not exceeding $2,000 in cash to have its current news release produced in video format. The corporate information is based on information that is publicly available. Any information provided by InvestmentPitch Media Ltd., through its media services is not to be construed as a recommendation or suggestion or offer to buy or sell securities but is provided solely as an informational media service. InvestmentPitch Media Ltd makes no warranties or undertakings as to the accuracy or completeness of this information. All due diligence should be done by the viewer or their financial advisor. Investing in securities is speculative and carries risk.
About InvestmentPitch Media
InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company’s story ahead of the 1,000’s of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
Cannabis
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
SCHWAZZE2 weeks ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis6 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis5 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan4 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey